Showing results (41-50 of 198) with videos related to
Sort By:
Pageof 20
Breast Cancer Research and Treatment|June 27, 2002
Effect of selective ablation of proliferating mammary epithelial cells on MNU induced rat mammary tumorigenesisLakshmi Sivaraman, Jason Gay, Susan G Hilsenbeck, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 7, 2010
Drain data to predict clinically relevant pancreatic fistulaDaniel J Moskovic, Sally E Hodges, Meng-Fen Wu, et al.The Oncologist|November 8, 2014
A phase II trial of capecitabine concomitantly with whole-brain radiotherapy followed by capecitabine and sunitinib for brain metastases from breast cancerPolly Niravath, Yee Lu Tham, Tao Wang, et al.Oncotarget|February 20, 2016
The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expressionJonathan H Shepherd, Ivan P Uray, Abhijit Mazumdar, et al.Gastro Hep Advances|August 4, 2025
Comparative Analysis of Imaging Modalities for Surveillance on Outcomes in Patients With Hepatocellular CarcinomaAhmed El Sabagh, Islam Mohamed, Mazen ElSheikh, et al.Archives of Internal Medicine|March 30, 2005
Research with stored biological samples: what do research participants want?Donna T Chen, Donald L Rosenstein, Palaniappan Muthappan, et al.Cancer Research|November 19, 2009
Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cellsLu Chen, Julie Ann Mayer, Tibor I Krisko, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Association between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancerMatthew H Herynk, Irma Parra, Yukun Cui, et al.Cancer Research|October 16, 2010
Hippo pathway effector Yap is an ovarian cancer oncogeneChad A Hall, Runsheng Wang, Jiangyong Miao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosisChad J Creighton, Angelo Casa, ZaWaunyka Lazard, et al.Pageof 20